Literature DB >> 19380796

Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells.

Jennifer R Kiesel1, Zachary S Buchwald, Rajeev Aurora.   

Abstract

Bone is remodeled throughout the life of an animal by the action of osteoclasts, which resorb bone, and osteoblasts, which form new bone. It has recently been recognized that T cells regulate osteoclasts by secreting a number of cytokines including type I and II IFNs and receptor activator of NF-kappaB ligand. In this study, we show that osteoclasts produce chemokines that recruit CD8(+) T cells. Using transgenic OT-I mice, we found that in the presence of OVA, osteoclasts induced the secretion of IL-2, IL-6, and IFN-gamma as well as the proliferation of CD8(+) T cells. CD8(+) T cells activated by osteoclasts expressed FoxP3, CTLA4, and receptor activator of NF-kappaB ligand. The FoxP3(+)CD8(+) T cells were anergic and suppressed dendritic cell priming of naive responder CD8(+) T cells. These results provide two novel observations for osteoimmunology: first, we demonstrate that osteoclasts can cross-present Ags to CD8(+) T cells. Second, these data show that osteoclasts are not only regulated by T cells, but they also can regulate T cells forming a feedback control loop. The induction of FoxP3 in T cells through a MHC class I-dependent manner provides a new mechanism to peripherally produce a regulatory T cell. These observations open a new avenue of investigation for the pathogenesis of autoimmune-mediated inflammatory bone diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380796     DOI: 10.4049/jimmunol.0803897

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Interactions between the immune system and bone.

Authors:  Patrizia D'Amelio; Giorgia Fornelli; Ilaria Roato; Giovanni Carlo Isaia
Journal:  World J Orthop       Date:  2011-03-18

2.  Cross-talk between T cells and osteoclasts in bone resorption.

Authors:  Lucia D'Amico; Ilaria Roato
Journal:  Bonekey Rep       Date:  2012-06-06

Review 3.  Macrophage diversity in cardiac inflammation: a review.

Authors:  Jobert G Barin; Noel R Rose; Daniela Ciháková
Journal:  Immunobiology       Date:  2011-06-30       Impact factor: 3.144

Review 4.  Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.

Authors:  Leah M Cook; Gemma Shay; Arturo Araujo; Arturo Aruajo; Conor C Lynch
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

5.  Osteoclast-Primed Foxp3+ CD8 T Cells Induce T-bet, Eomesodermin, and IFN-γ To Regulate Bone Resorption.

Authors:  Elena V Shashkova; Jahnavi Trivedi; Anna B Cline-Smith; Chloe Ferris; Zachary S Buchwald; Jesse Gibbs; Deborah Novack; Rajeev Aurora
Journal:  J Immunol       Date:  2016-06-20       Impact factor: 5.422

6.  Increased numbers of nonattached osteoclasts after long-term zoledronic acid therapy in mice.

Authors:  Shinichiro Kuroshima; Virginia-Arlene A Go; Junro Yamashita
Journal:  Endocrinology       Date:  2011-11-22       Impact factor: 4.736

7.  Differentiation and Phenotyping of Murine Osteoclasts from Bone Marrow Progenitors, Monocytes, and Dendritic Cells.

Authors:  Julia Halper; Maria-Bernadette Madel; Claudine Blin-Wakkach
Journal:  Methods Mol Biol       Date:  2021

8.  Pulsed low-dose RANKL as a potential therapeutic for postmenopausal osteoporosis.

Authors:  Anna Cline-Smith; Jesse Gibbs; Elena Shashkova; Zachary S Buchwald; Deborah V Novack; Rajeev Aurora
Journal:  JCI Insight       Date:  2016-08-18

Review 9.  Osteoclasts-Key Players in Skeletal Health and Disease.

Authors:  Deborah Veis Novack; Gabriel Mbalaviele
Journal:  Microbiol Spectr       Date:  2016-06

Review 10.  Osteoclasts: more than 'bone eaters'.

Authors:  Julia F Charles; Antonios O Aliprantis
Journal:  Trends Mol Med       Date:  2014-07-06       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.